Patents by Inventor Kristian Bangert

Kristian Bangert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and devices for rapid assessment of severity of injury
    Patent number: 11125761
    Abstract: Methods and devices for rapid assessment of the severity of injury not due to a natural disease based upon measurement of neutrophil gelatinase-associated lipocalin (NGAL) are provided.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: September 21, 2021
    Assignee: Antibodyshop A/S
    Inventors: Kristian Bangert, Lars Otto Uttenthal
  • Diagnostic Test to Exclude Significant Renal Injury
    Publication number: 20190170770
    Abstract: Methods for determining the risk of developing acute renal failure in a human subject by measuring human neutrophil gelatinase-associated lipocalin (NGAL) are provided.
    Type: Application
    Filed: February 7, 2019
    Publication date: June 6, 2019
    Inventors: Lars Uttenthal, Kristian Bangert
  • Methods and Devices for Rapid Assessment of Severity of Injury
    Publication number: 20180172710
    Abstract: Methods and devices for rapid assessment of the severity of injury not due to a natural disease based upon measurement of neutrophil gelatinase-associated lipocalin (NGAL) are provided.
    Type: Application
    Filed: February 6, 2018
    Publication date: June 21, 2018
    Inventors: Kristian BANGERT, Lars Otto UTTENTHAL
  • Methods and devices for rapid assessment of severity of injury
    Patent number: 9927446
    Abstract: Methods and devices for rapid assessment of the severity of injury not due to a natural disease based upon measurement of neutrophil gelatinase-associated lipocalin (NGAL) are provided.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: March 27, 2018
    Assignee: Antibosyshop A/S
    Inventors: Kristian Bangert, Lars Otto Uttenthal
  • Methods for Safe Administration of Nephrotoxic Agents
    Publication number: 20160109463
    Abstract: Methods for determining the risk of developing acute renal failure in a human subject by measuring human neutrophil gelatinase-associated lipocalin (NGAL) are provided.
    Type: Application
    Filed: December 29, 2015
    Publication date: April 21, 2016
    Inventors: Lars Otto UTTENTHAL, Kristian BANGERT
  • Treatment of Acute Tubular Necrosis or Acute Tubule-Interstitial Nephropathy
    Publication number: 20160003851
    Abstract: Methods for treating, monitoring and diagnosing renal disorders including measuring human neutrophil gelatinase-associated lipocalin (NGAL) are provided.
    Type: Application
    Filed: September 16, 2015
    Publication date: January 7, 2016
    Inventors: Lars Otto Uttenthal, Margarita Ghiglione Juanes, Kristian Bangert
  • Methods and Devices for Rapid Assessment of Severity of Injury
    Publication number: 20150323552
    Abstract: Methods and devices for rapid assessment of the severity of injury not due to a natural disease based upon measurement of neutrophil gelatinase-associated lipocalin (NGAL) are provided.
    Type: Application
    Filed: July 17, 2015
    Publication date: November 12, 2015
    Inventors: Kristian Bangert, Lars Otto Uttenthal
  • Determination of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Diagnostic Marker for Renal Disorders
    Publication number: 20150132772
    Abstract: Methods for diagnosing renal disorders by measuring human neutrophil gelatinase-associated lipocalin (NGAL) are provided.
    Type: Application
    Filed: January 8, 2015
    Publication date: May 14, 2015
    Inventors: Lars Otto Uttenthal, Margarita Ghiglione Juanes, Kristian Bangert
  • Methods and Devices for Rapid Assessment of Severity of Injury
    Publication number: 20150064730
    Abstract: Methods and devices for rapid assessment of the severity of injury not due to a natural disease based upon measurement of neutrophil gelatinase-associated lipocalin (NGAL) are provided.
    Type: Application
    Filed: November 10, 2014
    Publication date: March 5, 2015
    Inventors: Kristian Bangert, Lars Otto Uttenthal
  • Diagnostic test for renal injury
    Patent number: 8313919
    Abstract: A method is provided of diagnosing and monitoring acute renal injury leading to acute renal failure in a human or mammalian subject by determining the ratio of the concentration of neutrophil gelatinase-associated lipocalin (NGAL) in urine to that in plasma or serum.
    Type: Grant
    Filed: March 18, 2008
    Date of Patent: November 20, 2012
    Assignee: BioPorto Diagnostics A/S
    Inventors: Lars Otto Uttenthal, Kristian Bangert
  • Assessment of patients with sepsis to determine a requirement for therapeutic intervention with an anti-inflammatory and/or anticoagulatory agent
    Patent number: 8101366
    Abstract: Methods of selecting patients with sepsis for treatment with an anti-inflammatory and/or anticoagulatory agent are provided.
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: January 24, 2012
    Assignee: AntibodyShop A/S
    Inventors: Kristian Bangert, Lars Otto Uttenthal
  • DIAGNOSTIC USE OF INDIVIDUAL MOLECULAR FORMS OF A BIOMARKER
    Publication number: 20100304413
    Abstract: Methods are provided of diagnosing, monitoring or determining the severity of disease or injury by measuring individual molecular forms of neutrophil gelatinase-associated lipocalin (NGAL) in bodily fluids, including the diagnosis and monitoring of acute renal injury leading to acute renal failure in a human or mammalian subject by determining the concentration of the free monomer form of NGAL.
    Type: Application
    Filed: November 14, 2008
    Publication date: December 2, 2010
    Inventors: Lars Otto Uttenthal, Kristian Bangert
  • Diagnostic Test to Exclude Significant Renal Injury
    Publication number: 20100210031
    Abstract: Methods for determining the risk of developing acute renal failure in a human subject by measuring human neutrophil gelatinase-associated lipocalin (NGAL) are provided.
    Type: Application
    Filed: August 3, 2007
    Publication date: August 19, 2010
    Applicant: AntibodyShop A/S
    Inventors: Lars Uttenthal, Kristian Bangert
  • Assessment of Patients with Sepsis to Determine a Requirement for Therapeutic Intervention with an Anti-Inflammatory and/or Anticoagulatory Agent
    Publication number: 20100047832
    Abstract: Methods of selecting patients with sepsis for treatment with an anti-inflammatory and/or anticoagulatory agent are provided.
    Type: Application
    Filed: December 19, 2007
    Publication date: February 25, 2010
    Inventors: Kristian Bangert, Lars Otto Uttenthal
  • Diagnostic Test for Renal Injury
    Publication number: 20100035364
    Abstract: A method is provided of diagnosing and monitoring acute renal injury leading to acute renal failure in a human or mammalian subject by determining the ratio of the concentration of neutrophil gelatinase-associated lipocalin (NGAL) in urine to that in plasma or serum.
    Type: Application
    Filed: March 18, 2008
    Publication date: February 11, 2010
    Inventors: Lars Otto Uttenthal, Kristian Bangert
  • Diagnostic Test to Exclude Significant Renal Injury
    Publication number: 20090311801
    Abstract: Methods for determining the risk of developing acute renal failure in a human subject by measuring human neutrophil gelatinase-associated lipocalin (NGAL) are provided.
    Type: Application
    Filed: August 3, 2007
    Publication date: December 17, 2009
    Applicants: China Petroleum & Chemical Corporation, Research Institute of Petroleum Processing, Sinopec
    Inventors: Lars Otto Uttenthal, Kristian Bangert
  • Methods and Devices for Rapid Assessment of Severity of Injury
    Publication number: 20090197280
    Abstract: Methods and devices for rapid assessment of the severity of injury not due to a natural disease based upon measurement of neutrophil gelatinase-associated lipocalin (NGAL) are provided.
    Type: Application
    Filed: May 30, 2007
    Publication date: August 6, 2009
    Inventors: Kristian Bangert, Lars Otto Uttenthal
  • Determination of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Diagnostic Marker for Renal Disorders
    Publication number: 20090170143
    Abstract: Methods for diagnosing renal disorders by measuring human neutrophil gelatinase-associated lipocalin (NGAL) are provided.
    Type: Application
    Filed: December 20, 2005
    Publication date: July 2, 2009
    Inventors: Lars Otto Uttenthal, Margarita Ghiglione Juanes, Kristian Bangert